NCT06117839

Brief Summary

Our study will be a prospective study To compare between the rate of infection after using antibiotic loaded cement and regular cement after total knee arthroplasty in primary knee osteoarthritis.this will be at assiut university trauma hospital .There are 2 groups ,first group is patients will be treated with regular bone cement ,the second one is patient will be treated with antibiotic loaded bone cement, commonly used antibiotics includeGentamycin powder.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
24 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

November 24, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

October 31, 2023

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Infection eradication rate

    patients will be evaluated clinically and undergo lab evaluation (CRP and CBC).Patients will be routinely monitored for clinical signs of infection, including cellulitis or draining sinuses. Radiographs will be obtained at 2,6 and 12 months. * Laboratory tests as CRPwill be used to assess the infection. * A negative CRP indicate clean field and eradication of infection.

    12 months postoperative

Secondary Outcomes (1)

  • Cost/benefit ratio.

    12 months postoperative

Study Arms (2)

1

first group is patients will be treated with regular bone cement . Patients will be routinely monitored for clinical signs of infection, including cellulitis or draining sinuses. Radiographs were obtained at 2,6 and 12 months. * Laboratory tests as CRP and CBC will beused to assess the infection. * A negative CRP indicate clean field .

Procedure: using antibiotic loaded cement and regular cement after total knee arthroplasty in primary knee osteoarthritis.

2

the second one is patient will be treated with antibiotic loaded bone cement, commonly used antibiotic includeGentamycin powder. Patients will beroutinely monitored for clinical signs of infection, including cellulitis or draining sinuses. Radiographs were obtained at 2,6 and 12 months. * Laboratory tests as CRP and CBC used to assess the infection. * A negative CRP indicate clean field.

Procedure: using antibiotic loaded cement and regular cement after total knee arthroplasty in primary knee osteoarthritis.

Interventions

-There are 2 groups ,first group is patients will betreated with regular bone cement ,the second one is patient will be treated with antibiotic loaded bone cement, commonly used antibiotics include Gentamycin powder .

12

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patient undergo TKA in primary osteoarthritis. Patient with rheumatoid knee osteoarthritis. Patient with post-traumatic knee osteoarthritis, Patient with knee tumor. Patient has allergy to antibiotics used in the study or Patient with any operative procedure in the knee are excluded.

You may qualify if:

  • Patient with primary knee osteoarthritis.
  • Patient underwent total knee arthroplasty.

You may not qualify if:

  • Patient with rheumatoid knee osteoarthritis.
  • Patient with post-traumatic knee osteoarthritis.
  • Patient with knee tumor.
  • Patient has allergy to antibiotics used in the study.
  • Patient with any operative procedure in the knee.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Ahmed Sallam Abo El-azaiem, bachelor's

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident physcian at orthopedic surgery and truamatology

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 7, 2023

Study Start

December 1, 2023

Primary Completion

December 1, 2024

Study Completion

January 1, 2025

Last Updated

November 24, 2023

Record last verified: 2023-11